These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4601745)

  • 1. Treatment of malignant melanoma with methyl CCNU.
    Young RC; Canellos GP; Chabner BA; Schein PS; Brereton HD; DeVita VT
    Clin Pharmacol Ther; 1974 Jun; 15(6):617-22. PubMed ID: 4601745
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II study of CCNU (NSC-79037) in the treatment of advanced gastrointestinal cancer.
    Klaassen DJ; Rapp E
    Cancer Chemother Rep; 1974; 58(5 Pt 1):667-9. PubMed ID: 4426046
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of a nitrosourea (CCNU, NSC-79037) in advanced nonhematologic cancer.
    Perloff M; Muggia FM; Ackerman C
    Cancer Chemother Rep; 1974; 58(3):421-4. PubMed ID: 4841718
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination chemotherapy with adriamycin (NSC-123127) and 1-(2-chloroethyl)-3-cyclohexyl 1-nitrosourea (CCNU; NSC-79037).
    Einhorn LH; Livingston RB; Gottlieb JA
    Cancer Chemother Rep; 1973; 57(4):437-45. PubMed ID: 4586951
    [No Abstract]   [Full Text] [Related]  

  • 5. Lomustine treatment of metastatic renal cell carcinoma.
    Mittelman A; Albert DJ; Murphy GP
    JAMA; 1973 Jul; 225(1):32-5. PubMed ID: 4740302
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and imidazole carboxamide (NSC 45388) with vincristine (NSC 67574) in the palliation of disseminated malignant melanoma.
    Ahmann DL; Hahn RG; Bisel HF
    Cancer Res; 1972 Nov; 32(11):2432-4. PubMed ID: 5082592
    [No Abstract]   [Full Text] [Related]  

  • 7. Initial clinical trials with methyl-CCNU 1-(2-chlorethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (MeCCNU).
    Young RC; Walker MD; Canellos GP; Schein PS; Chabner BA; DeVita VT
    Cancer; 1973 May; 31(5):1164-9. PubMed ID: 4705154
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of 1-(2-chloroethyl-3-4-methylcyclohexyl)-1-nitrosourea (methyl-CCNU, NSC 95441) versus combined imidazole carboxamide (NSC 45338) and vincristine (NSC 67574) in palliation of disseminated malignant melanoma.
    Ahmann DL; Hahn RG; Bisel HF
    Cancer; 1974 Mar; 33(3):615-8. PubMed ID: 4131357
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of 5-azacytidine (NSC-102816) with CCNU (NSC-79037) in the treatment of patients with breast cancer and evaluation of the subsequent use of cyclophosphamide (NSC-26271).
    Cunningham TJ; Nemoto T; Rosner D; Knight E; Taylor S; Rosenbaum C; Horton J; Dao T
    Cancer Chemother Rep; 1974; 58(5 Pt 1):677-81. PubMed ID: 4138966
    [No Abstract]   [Full Text] [Related]  

  • 10. Topical lomustine in the treatment of psoriasis.
    Peck GL; Guss SB; Key DJ
    Arch Dermatol; 1972 Aug; 106(2):172-6. PubMed ID: 4558698
    [No Abstract]   [Full Text] [Related]  

  • 11. Preliminary clinical trial of 1-(2-chlorethyl)-3-(4-methylcyclohexyl)-1 nitrosourea (NSC-95411) (MeCCNU) in human neoplasms.
    Gailani S; Kutcher J
    J Med; 1973; 4(4):209-18. PubMed ID: 4520348
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination CCNU and bleomycin therapy for squamous cell carcinoma.
    Lindell TD; Moseley HS; Fletcher WS
    Am Surg; 1974 May; 40(5):281-9. PubMed ID: 4132376
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the therapy of lymphogranuloma. CCNU (1(2-chlorethyl)-3-cyclohexyl-1-nitrosourea) and BCNU (1,3-bis(2-chlorethyl)-1-nitrosourea) as well as BCNU combinations in Hodgkin's lymphogranuloma, stage 3 and 4].
    Brunner KW; Maurice P; Sonntag RW
    Schweiz Med Wochenschr; 1972 Oct; 102(43):1546-51. PubMed ID: 4647016
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy of malignant melanoma with dimethyl traizeno imidazole carboxamide (DITC) and nitrosourea derivatives (BCNU, CCNU).
    Hill GJ; Ruess R; Berris R; Philpott GW; Parkin P
    Ann Surg; 1974 Aug; 180(2):167-74. PubMed ID: 4601984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comment on topical lomustine therapy for psoriasis.
    Kligman AM
    Arch Dermatol; 1973 Aug; 108(2):273-4. PubMed ID: 4269285
    [No Abstract]   [Full Text] [Related]  

  • 16. Growth curve modification of measurable tumors by 75 mg/m2 of CCNU every 3 weeks.
    Israel L; Chahinian P; Accard JL; Choffel C; Combes PF; Danrigal A; Germouty J; Migueres J; Schaerer R; Sotto JJ
    Eur J Cancer (1965); 1973; 9(11-12):789-97. PubMed ID: 4804306
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapy of advanced gastrointestinal cancer with the nitrosoureas.
    Moertel CG
    Cancer Chemother Rep 3; 1973 May; 4(3):27-34. PubMed ID: 4748872
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative toxicity on leukocytes and platelets of two regimens of CCNU: the relationship between maximum dose and optimum dose.
    Israel L; Chahinian P
    Eur J Cancer (1965); 1973; 9(11-12):799-802. PubMed ID: 4374357
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination chemotherapy with 1-(2-chloroethyl-3-cyclohexyl-1-nitrosourea) (CCNU), vincristine and methotrexate in primary and metastatic brain tumors--a preliminary report.
    Hildebrand J; Brihaye J; Wagenknecht L; Michel J; Kenis Y
    Eur J Cancer (1965); 1973 Sep; 9(9):627-34. PubMed ID: 4803230
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristine.
    Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ
    J Natl Cancer Inst; 1975 Jan; 54(1):69-71. PubMed ID: 1117460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.